CAU
TECH icon

Caxton Associates (UK)’s Bio-Techne TECH Stock Holding History

Caxton Associates (UK)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Buy
+10,296
New +$556K 0.01% 471

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Caxton Associates (UK)'s TECH Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Bio-Techne (TECH) in Q2 2026: 10,296 shares worth $727K. The stake represents 0.01% of the portfolio and ranks #471 among its holdings.

593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Caxton Associates (UK) held 10,296 shares of Bio-Techne worth $727K as of Q2 2026.
  • Bio-Techne was a new Caxton Associates (UK) position in Q2 2026.
  • Bio-Techne made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #471 holding.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.